logo

For the Inventor, By the Inventor

Cheshire, CT, United States of America

Yong Tu

LinkedIn

This inventor holds 17 USPTO granted patents and 7 published patent applications and 10 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, P2 Science, Inc., Viiv Healthcare UK (No.5) Limited. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Tu. Retrieved from https://idiyas.com/inventor/yong-tu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 88.2

 

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 155(Granted Patents)


Location History:

  • Wallingford, CT (US) (2018 - 2019)
  • Cheshire, CT (US) (2005 - 2024)

Company Filing History:

goldMedal12 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal2 out of 36 
 
P2 Science, Inc.
 patents
bronzeMedal2 out of 45 
 
Viiv Healthcare UK (No.5) Limited
 patents
4. 1 out of 2 
 
Birstol-Myers Squibb Company
 patents

Years Active: 2005-2024

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 11926577 - Method for synthesis of 2-methyl-2-hydroxyheptane and 2-methyl 2-alkoxyheptanes (2024-03-12),
2. 11919849 - Methods for hydrodealkenylation (2024-03-05),
3. 10617675 - Hepatitis C virus inhibitors (2020-04-14),
4. 10351546 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-07-16),
5. 10106504 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2018-10-23),
6. 9770439 - Hepatitis C virus inhibitors (2017-09-26),
7. 9717712 - Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus (2017-08-01),
8. 9326973 - Hepatitis C virus inhibitors (2016-05-03),
9. 8129367 - Compounds for the treatment of Hepatitis C (2012-03-06),
10. 7547690 - Compounds for the treatment of Hepatitis C (2009-06-16),
11. 7541353 - Compounds for the treatment of hepatitis C (2009-06-02),
12. 7538103 - Compounds for the treatment of hepatitis C (2009-05-26),
13. 7538102 - Compounds for the treatment of Hepatitis C (2009-05-26),
14. 7521444 - Compounds for the treatment of hepatitis C (2009-04-21),
15. 7473688 - Indolobenzazepine HCV NS5B inhibitors (2009-01-06),

Title: Inventor Yong Tu - Revolutionizing Technology in Cheshire

Introduction: Yong Tu, a distinguished inventor based in Cheshire, CT, is renowned for his groundbreaking contributions to the field of technology. With a keen eye for innovation and a passion for creating solutions, Tu has made a significant impact on various industries.

Latest Patents: Tu's latest patents showcase his ingenuity and forward-thinking approach to technology. His recent inventions have focused on enhancing efficiency, improving user experience, and pushing the boundaries of what is possible in the digital landscape.

Career Highlights: Throughout his illustrious career, Yong Tu has garnered recognition for his exceptional work in developing cutting-edge technologies. His ability to translate complex ideas into practical applications has set him apart as a visionary in the industry.

Collaborations: Tu has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in driving innovation forward and ensuring that his creations have a lasting impact on the world.

Conclusion: In conclusion, Yong Tu's dedication to innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the field of technology. His inventive spirit continues to inspire others to push the boundaries of what is possible, making him a true pioneer in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…